2022
DOI: 10.1080/17425247.2022.2147504
|View full text |Cite
|
Sign up to set email alerts
|

Needle-free injection of basal insulin improves fasting glucose variability as assessed by continuous glucose monitoring in T2DM: a prospective randomized multicenter open-label crossover study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 36 publications
0
1
0
Order By: Relevance
“…There are different types of insulin, such as needle-free insulin injector (NFII), continuous insulin infusion (CSII), multiple subcutaneous insulin (MSI), and visfatin gene variation. NFII injects basal insulin to improve fasting glucose variation in T2DM patients [8]. CSII treatment reduces glucose levels faster with a lower dosage of insulin [9].…”
Section: Introductionmentioning
confidence: 99%
“…There are different types of insulin, such as needle-free insulin injector (NFII), continuous insulin infusion (CSII), multiple subcutaneous insulin (MSI), and visfatin gene variation. NFII injects basal insulin to improve fasting glucose variation in T2DM patients [8]. CSII treatment reduces glucose levels faster with a lower dosage of insulin [9].…”
Section: Introductionmentioning
confidence: 99%